Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
Condition(s):HER2 Negative Breast CancerLast Updated:January 11, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):HER2 Negative Breast CancerLast Updated:January 11, 2024Recruiting
Condition(s):HER2-negative Breast CancerLast Updated:March 3, 2022Not yet recruiting
Condition(s):HER2-negative Breast CancerLast Updated:May 21, 2021Unknown status
Condition(s):HER2-negative Breast Cancer; Advanced Solid TumorLast Updated:April 18, 2023Recruiting
Condition(s):HER2-Negative Breast CancerLast Updated:July 21, 2020Unknown status
Condition(s):Luminal B/HER2-negative Breast CancerLast Updated:January 31, 2024Recruiting
Condition(s):HER2-negative Breast CancerLast Updated:September 3, 2020Unknown status
Condition(s):Breast CancerLast Updated:January 10, 2024Not yet recruiting
Condition(s):HER2-negative Breast Cancer; Triple Negative Breast CancerLast Updated:March 2, 2023Recruiting
Condition(s):Breast Cancer; MelanomaLast Updated:March 6, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.